Healthcare centre Nis

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials

Phase

• Phase 32 trials

Status

• Completed1 trial
• Withdrawn1 trial

Lead sponsor

• Novo Nordisk A/S2 trials

Closed trials

• Completed

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin

  NCT06323161· Phase 3· Novo Nordisk A/S· Source

• Withdrawn

  Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes

  NCT06083675· Phase 3· Novo Nordisk A/S· Source